In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Focus-logo.png

on Management of Cardiovascular Disease in the Elderly

 

 

In older adults, cardiovascular disease may present in atypical ways, with variations in disease progression influenced by the individual degree of comorbidity and frailty.

Enhancing knowledge and confidence in the use of validated tools to assess comorbidity and frailty represents an important opportunity for improving care. In clinical practice, patients with diabetes and other comorbidities are often perceived as being less closely monitored and having lower treatment adherence compared to healthier, more robust adults.

This month’s FOCUS highlights specific recommendations to address cardiovascular disease in older patients from relevant ESC guidelines and clinical consensus statements. Developed with feedback from 58 National Cardiac Societies, two dedicated webinars on existing advice for older adults aim to identify key domains and components of frailty, alongside specialised cardio-geriatric approaches to managing cardiovascular diseases. The webinars also explore the implementation of best clinical practice drawing on the latest evidence from recent trials involving hypertension, antithrombotic, lipid lowering, and cardiometabolic therapies.

The content below was selected by Luigina Guasti, Konstantinos Toutouzas, and Marc Ferrini to help guide a targeted approach, effective assessments and more comprehensive management of cardiovascular disease in older adults.

 

 

 

Webinars

Management of cardiovascular disease in older adults

Cardiogeriatric assessments and evaluation of frailty
04 June
With Doctor R. Asteggiano (Turin, IT), Professor J. Afilalo (Montreal, CA), Associate Professor L. Guasti (Varese, IT)

New evidence from recent trials
16 June
With Professor K. Toutouzas (Athens, GR), Doctor M. Ferrini (Lyon, FR), Associate Professor S. Fumagalli (Florence, IT)

Essentials


ESC Guidelines
ESC Guidelines

 2023 ESC Guidelines on Acute Coronary Syndromes - Chapter 12.3.4. Older adults with frailty and multimorbidity

 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes - Chapter 12 Person-centred care

 2023 ESC Guidelines for the management of cardiomyopathies - Chapter 7.7. Amyloidosis

 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice - Chapter 6.7 Multimorbidity

 2021 ESC Guidelines on Valvular Disease

 2024 ESC Guidelines for the management of atrial fibrillation - Chapter 5. Comorbidity and risk factor management, Chapter 9.13. AF-CARE in older, multimorbid, or frail patients

 2018 ESC/EACTS Myocardial Revascularization

 2024 ESC guidelines of elevated blood pressure and hypertension

 2024 ESC Guidelines for the Management of Atrial Fibrillation AF-CARE: “C” Comorbidity and risk factor management

 2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases

 Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies:  Considerations for lifetime management of aortic stenosis

 Heart failure is the stage and amyloid a key player:  Epidemiology of amyloidosis in heart failure and red flags

 Management of dyslipidaemias in the elderly:  how to implement the guidelines and take-home message

 From TAVI over mitral and tricuspid transcatheter interventions to cardiac and non-cardiac surgery: is it useful to assess frailty?

 Is reversal of frailty a good strategy to optimise the clinical outcomes after cardiac interventions?



Dig deeper

Exclusive for members


Banner-Guidelines-App-2024-970x90.jpg